GlassScriptPhysician profile
Marina Torbey
NPI 1619084225
$548.22
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $36.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $162.42 | 2019 | |
| Abbott Laboratories | $138.30 | 2019 | |
| Therapeuticsmd, INC. | $57.91 | 2019 | |
| Allergan, INC. | $37.62 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.11 | 2019-2020 | |
| Millicent US INC | $27.75 | 2019 | |
| Covidien LP | $23.47 | 2019 | |
| Ironshore Pharmaceuticals INC. | $20.33 | 2020 | |
| Alexion Pharmaceuticals, INC. | $20.15 | 2019 | |
| Novum Pharma, LLC | $15.60 | 2019 | |
| Pfizer INC. | $13.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Torbey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.